Research

Against all odds and contrary to popular wisdom, NYU Langone works magic with a hospital merger.

Several types of antibiotic-resistant microbes were found in the digestive system of patients with COVID-19.

The researchers think therapies targeted at KRAS mutations can flag target proteins for immunotherapy attack.

Finding key biomarkers could lead to earlier, faster diagnosis.

New biotechnology uses targeted drugs to mark them for another kind of attack.

Dr. Dafna Bar-Sagi’s research examines how different levels of the environment affect tumor behavior.

Blocking calcium signals’ action in immune cells counters asthma without reducing flu defenses, study shows.

The norovirus infection blocks the release of protein meant to protect gut lining cells from damage.

Dr. Janice Mehnert says giving pembrolizumab before and after surgery is a potentially new standard of care.

The findings may help explain how the coronavirus continues to develop resistance to treatment.